This Viewpoint discusses whether or not the evidence cited in the 2021 American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography & Interventions guidelines for coronary artery revascularization support downgrading coronary artery bypass grafting relative to medical therapy.